{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Badr H"],"funding":["National Cancer Institute","NCI NIH HHS"],"pagination":["e7306"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11306290"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13(15)"],"pubmed_abstract":["<h4>Purpose</h4>This study aimed to develop and validate FinTox, a concise tool for screening and managing financial toxicity in oncology settings.<h4>Methods</h4>Development involved qualitative interviews with healthcare providers and patients, and feedback from a 7-member expert panel resulting in a 5-item measure that evaluates financial strain, psychological responses, and care modifications. Psychometric evaluations examined factor structure, internal consistency, test-retest reliability, and concurrent and convergent validity. Associations between FinTox scores and sociodemographic/medical factors were also analyzed using univariate and multivariable regression models.<h4>Results</h4>Twelve healthcare providers and 20 patients were interviewed, and 268 patients (69.8% female, 47.4% "],"journal":["Cancer medicine"],"pubmed_title":["Development and validation of FinTox: A new screening tool to assess cancer-related financial toxicity."],"pmcid":["PMC11306290"],"funding_grant_id":["P30 CA125123‐14S7","P30 CA125123","P30 CA125123-14S7"],"pubmed_authors":["Badr H","Han J","Mims M"],"additional_accession":[]},"is_claimable":false,"name":"Development and validation of FinTox: A new screening tool to assess cancer-related financial toxicity.","description":"<h4>Purpose</h4>This study aimed to develop and validate FinTox, a concise tool for screening and managing financial toxicity in oncology settings.<h4>Methods</h4>Development involved qualitative interviews with healthcare providers and patients, and feedback from a 7-member expert panel resulting in a 5-item measure that evaluates financial strain, psychological responses, and care modifications. Psychometric evaluations examined factor structure, internal consistency, test-retest reliability, and concurrent and convergent validity. Associations between FinTox scores and sociodemographic/medical factors were also analyzed using univariate and multivariable regression models.<h4>Results</h4>Twelve healthcare providers and 20 patients were interviewed, and 268 patients (69.8% female, 47.4% ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Aug","modification":"2026-06-04T05:32:14.268Z","creation":"2025-04-04T01:02:54.936Z"},"accession":"S-EPMC11306290","cross_references":{"pubmed":["39113222"],"doi":["10.1002/cam4.7306"]}}